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Abstract: Over the past several decades, obesity has grown into a major global epidemic. In the 
United States (US), more than two-thirds of adults are now overweight and one-third is obese. 
In this article, we provide an overview of the state of research on the likely economic impact 
of the US obesity epidemic at the national level. Research to date has identified at least four 
major categories of economic impact linked with the obesity epidemic: direct medical costs, 
productivity costs, transportation costs, and human capital costs. We review current evidence on 
each set of costs in turn, and identify important gaps for future research and potential trends in 
future economic impacts of obesity. Although more comprehensive analysis of costs is needed, 
substantial economic impacts of obesity are identified in all four categories by existing research. 
The magnitude of potential economic impact underscores the importance of the obesity epidemic 
as a focus for policy and a topic for future research.
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Introduction
Over the past several decades, obesity has grown into a major global epidemic. By 2002, 
nearly 500 million people were overweight worldwide. In the United States (US), 
rates of obesity have doubled since 1970 to over 30%, with more than two-thirds of 
  Americans now overweight.1 The determinants of this epidemic are likely complex,2,3 
with substantial heterogeneity at the individual level in both causes and consequences 
that is beyond the scope of the current review.
In this article, we provide an overview of the state of research on the likely 
  economic impact of the US obesity epidemic at the aggregate level. We conducted 
a broad search of the literature that addresses potential economic costs of obesity. 
The most recent studies that sample US populations have identified at least four major 
categories of economic impact linked with the obesity epidemic: direct medical costs, 
productivity costs, transportation costs, and human capital costs. We systematically 
review current evidence on each set of costs in turn, and discuss important gaps for 
future research along with potential trends in future economic impacts of obesity. This 
review adds to the current research on the economic impact of obesity by providing 
a more comprehensive overview of the range of effects, as well as a summary of the 
most up-to-date estimates.
Direct medical costs
One of the most cited economic impacts of the obesity epidemic is on direct medical 
spending. Obesity is linked with higher risk for several serious health conditions, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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such as hypertension, type 2 diabetes, hypercholesterolemia, 
coronary heart disease (CHD), stroke, asthma, and arthritis. 
Direct medical spending on diagnosis and treatment of these 
conditions, therefore, is likely to increase with rising obesity 
levels. Several studies offer retrospective or prospective 
estimates of the degree of disease incidence that can be 
linked to obesity, and of the magnitude of associated direct 
medical costs.
incidence of diseases associated  
with obesity
The most common definitions of obesity are based on body 
mass index (BMI), defined as weight in kilograms divided 
by height in meters squared. Obesity in adults is generally 
defined as a BMI of 30.0 or greater, with BMI of 25.0–29.9 
categorized as overweight.4
Thompson et al5 present a dynamic model of the relation-
ships between BMI and the risks of five diseases linked with 
obesity: hypertension, hypercholesterolemia, type 2 diabetes 
mellitus, CHD, and stroke. The model captures both direct 
and indirect effects of obesity on health outcomes – obesity 
is a risk factor for hypertension, hypercholesterolemia, and 
diabetes, which are themselves risk factors for CHD and 
stroke.   Estimated using a variety of data sources (including 
the National Health And Nutritional Examination Survey 
or NHANES, and the Framingham Study), the model gives 
future risks of all five diseases, life expectancy, and lifetime 
medical costs associated with the five diseases for men and 
women aged 35 to 64 years in each of four representative BMI 
groups (“healthy” BMI of 22.5, “overweight” BMI of 27.5, 
“obese” BMI of 32.5, and “severely obese” BMI of 37.5). BMI 
is assumed to be constant at its initial value for all   individuals, 
with other risk factors adjusted for each year of aging. Results 
from the model demonstrate substantial increases in disease 
risk with increasing BMI. Relative to the group with BMI of 
22.5, risk of hypertension is 40%–60% higher in the   overweight 
(BMI 27.5), and twofold higher in the obese (BMI 32.5). Life-
time risk of CHD is 41.8% in obese men compared to 34.9% 
in the nonobese; for women, risk increases from 25% for the 
nonobese to 32.4% for the obese.
Similar relative disease risk rates for the overweight 
and obese are found in large-scale population studies. The 
Health Professionals Follow-up Study, based on 29,000 men 
observed over a three year time-period, found CHD risk to 
be 50% higher in the overweight (BMI 25–28.9), twice as 
high in the obese (BMI 29–32.9), and three times as high in 
the severely obese (BMI . 33), compared to healthy weight 
men (BMI , 23).6 For women, analysis7 based on the Nurses 
Health Study8 found the relative risk of type 2 diabetes to be 
40.3 for women with BMIs between 31 and 32.9 (compared 
to those with BMI of less than 22). Analysis of NHANES-II 
cross-sectional data for both men and women found risk 
of hypertension and diabetes to be increased 3.0 times and 
2.9 times, respectively, compared to the nonoverweight.9,10 
A large-scale telephone survey of 195,000 adults11 found the 
odds ratio for the overweight and obese (compared to normal 
weight) to be 1.59 and 3.44, respectively for diabetes, 1.82 
and 3.50, respectively for high blood pressure, and 1.50 and 
1.91, respectively for high cholesterol. Statistically significant 
effects for asthma and arthritis were also found. A different 
study quantified an increase of 1 mmHg in systolic blood 
pressure resulting from each one-unit increase in BMI among 
healthy 20–29 year olds.12
Medical costs associated with incidence 
of obesity-related diseases
Associated with incidence of obesity-related diseases are 
direct medical costs for diagnosis and treatment of these 
conditions. Numerous studies estimate these costs, using 
a variety of methodologies including: cohort studies, case 
studies, dynamic models, nationwide representative surveys, 
regression analyses, and simulation forecasting. There is 
widespread agreement across this literature that the medical 
costs associated with obesity are substantial; however, there 
are important differences between the studies.
Two recent studies use cohorts drawn from managed care 
organizations to estimate relative costs for the obese and 
overweight compared to the nonoverweight. This approach 
allows for direct study of individual medical histories (and 
charged costs) with no aggregation, but relies on self-report 
for BMI and other initial data. Cohorts examined may not 
be nationally representative. Thompson et al13 base their 
estimates on a retrospective study conducted at Kaiser Per-
manente in Oregon, with 1,286 subjects who responded to 
a 1990 random sample survey. Respondents were between 
35 and 64 years old, had self-reported BMIs greater than 
20, were nonsmokers, and had no history of heart disease. 
Thompson et al sorted subjects into three categories – healthy, 
overweight, and obese – according to initial (1990) BMI. 
They followed each group over a nine year period, using 
electronic records and local retail prices to tally real costs 
for all inpatient care, outpatient services, and prescriptions. 
Results show significantly higher accumulated costs for the 
obese and overweight than for the healthy-weight group. The 
obese (BMI $ 30) had 36% higher average annual health 
care costs than the healthy-weight group, including 105% Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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higher prescription costs and 39% higher primary-care costs. 
The overweight (BMI 25–29) had 37% higher prescription 
costs and 13% higher primary-care costs than the healthy-
weight group.
Wolf14 and Pronk et al15 studied health care costs among 
a stratified random sample (n = 5,689) drawn from mem-
bers of a managed care organization in Minnesota aged 40 
and older. They compare total medical care charges over 
an 18-month period across BMI categories, controlling for 
age, race, sex, and chronic disease status. Results show that 
a one-unit increase in BMI translates to a 1.9% increase in 
median medical spending during the study period.
Several studies use dynamic models to estimate medical 
care costs associated with overweight and obesity over a 
substantial time period. Using a dynamic multi-stage model 
of the relationship between BMI and risk for five diseases 
strongly linked to weight status (see above), Thompson et al13 
generate associated medical care costs for each stage of 
the model. They find overweight (BMI 27.5) to increase 
expected lifetime medical care costs for the five diseases 
studied by almost 20% compared to the healthy-weight group 
(BMI 22.5). Obesity increases lifetime medical care costs for 
these diseases by 50% above baseline, and severe obesity can 
almost double them.
Gorsky et al9 construct three “hypothetical” cohorts of 
10,000 women each – one cohort with healthy weight, one 
overweight, and one obese. They begin each cohort at age 
40 years and extrapolate into the future through age 65 years, 
conducting incidence-based analysis of the excess costs 
associated with remaining overweight or obese over this 
time period. Results show that the obese cohort would incur 
excess costs of $53 million (with 3% annual discounting) 
over the 25 years, and the overweight cohort would incur 
excess costs of $22   million. Applying these results to the 
broader US population, the authors estimate that approxi-
mately $16 billion will be spent between 1996 and 2021 on 
treatment of health conditions associated with overweight 
and obesity in middle-aged American women.
Regression analysis based on nationally representative 
surveys is another widely-used approach in the literature on 
health care costs associated with obesity. Finkelstein et al16 
use data from the 1998 and 2006 Medical Expenditure Panel 
Surveys (MEPS) along with National Health Expenditure 
Accounts data on health spending to construct a regression 
that controls for demography, smoking status, and insurance 
status. They divide cost estimates among payers (Medicare, 
Medicaid, or private) and cost category (inpatient, outpatient, 
or prescription). Estimated medical costs of obesity are as 
high as $147 billion a year for 2008, or almost 10% of all 
medical spending. This is a substantial increase from their 
1998 estimate of $78.5 billion a year. The authors attribute the 
majority of this increase to higher prevalence of overweight. 
Private payers bear the majority of estimated costs, although 
public-sector spending is also substantial – Medicare 
spending would be an estimated 8.5% lower and Medicaid 
spending 11.8% lower in the absence of obesity. Across all 
payers, comparison of the obese to healthy-weight individu-
als shows 2006 medical spending that is 41.5% higher as a 
result of obesity.
Rather than providing a point-estimate of obesity’s 
impact on spending, Thorpe et al17 focus on assessing the 
link between increases in obesity prevalence and increases 
in spending over time. They use self-reported data on both 
medical conditions and BMI from two nationally representa-
tive surveys (the National Medical Expenditure survey and 
the Household Component of the MEPS), and construct a 
two-part regression controlling for key individual variables 
(such as demography, smoking, and insurance status). The 
regression estimates the “obesity-attributable” portion of 
per-capita health care spending increases between 1987 and 
2001 to be 27% (adjusted for inflation), with 12% due solely 
to increases in prevalence of obesity. Most of this increase 
was found to be due to spending on diabetes or hypertension 
specifically. At the beginning of the study period in 1987, per 
capita health care spending was estimated to be 15.2% higher 
for the obese than for healthy-weight individuals. By 2001, 
this gap had grown to 37%. The rate of growth in spending 
among the obese group was much higher than overall per 
capita spending growth.
Allison et al18 examine whether any of the direct medical 
costs of obesity estimated in previous studies might be offset 
by increased (early) mortality associated with obesity. They 
conclude that increased mortality may lower costs somewhat, 
though inclusion of this factor does not affect the qualitative 
conclusion that such costs are likely substantial.
Obesity-related medical costs occur not only in adult 
populations, but in children as well. The annual direct 
costs of childhood obesity in the US are estimated at about 
$14.3 billion.19,20 In addition to these immediate costs, 
  current childhood obesity implies future direct costs given 
that   overweight children and adolescents may become obese 
adults.21 Lightwood et al22 estimate the likely future economic 
burden that will result from current high rates of overweight 
in US adolescents. They simulate the costs of excess obesity 
(and associated diseases) among US adults aged 35 to 
64 years from 2020 to 2050. Results suggest that currently Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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existing levels of adolescent overweight will result in close 
to $45 billion in direct medical costs over this period, affect-
ing young as well as middle-aged adults. The authors argue 
that these costs may be unavoidable, with currently existing 
technologies unable to reduce significantly the likely future 
consequences of current adolescent overweight.
A pair of recent studies examines who ultimately bears 
the health care costs associated with obesity. Bhattacharya 
and Bundorf23 use data from the National Longitudinal 
Survey of Youth (NLSY), collected by the Bureau of Labor 
Statistics (BLS), to capture worker wage information and 
the MEPS to capture medical expenditure information. 
Their regression analysis concludes that many of the health 
care costs associated with obesity “are passed on to obese 
  workers with employer-sponsored health insurance in the 
form of lower cash wages”. The authors argue that this gap 
in health-insurance premiums may explain most of the wage 
gap usually attributed to discrimination.
Dall et al24 focus specifically on diabetes, estimating that 
the US national economic burden of pre-diabetes and diabetes 
was $153 billion in higher medical costs for the year 2007 
alone, with an average annual medical cost per case of $1,744 
for undiagnosed diabetes, $6,649 for diagnosed diabetes, and 
$443 for pre-diabetes. Although this study does not estimate 
the fraction of these diabetes costs that are attributable to 
obesity, other evidence suggests it may be substantial (see 
above). Dall et al argue that the costs of diabetes are borne 
by all Americans, not only those with diabetes, and amount 
to a per-person cost of around $700 a year.
Productivity costs
In addition to direct medical costs of obesity, a number of 
more indirect costs are part of the overall economic impact 
of obesity. Of these, effects on productivity play the largest 
role empirically. The productivity costs of obesity have been 
well-documented in a variety of studies, with widespread 
consensus that such costs are substantial, but with important 
differences in magnitude between the individual estimates.
The literature in this area includes analyses of the aggre-
gate productivity loss due to obesity, as well as estimates for 
several distinct sub-categories of productivity costs. Many 
of these categories relate to productivity loss originating in 
the labor market, including ‘absenteeism’ (first-order pro-
ductivity costs due to employees being absent from work for 
obesity-related health reasons) and ‘presenteeism’ (decreased 
productivity of employees while at work). Other categories of 
productivity costs that have been analyzed thus far include: 
premature mortality and loss of quality-adjusted life years 
(QALYs); higher rates of disability benefit payments; and 
welfare loss in the health insurance market.
Absenteeism
Due to relative ease of measurement, studies estimating the 
absenteeism costs of overweight and obesity make up the 
largest category of productivity cost studies to date. Meth-
odologies vary, though the studies consistently find strong 
correlation between obesity and higher rates of absenteeism. 
Rather than giving an exhaustive review of absenteeism 
studies, we summarize here key findings and methodological 
differences across several recent papers that have addressed 
the relationship between obesity and absenteeism and the 
associated costs.
Studies vary by the measures used to identify obesity – 
the most common is BMI, but several studies use weight 
directly (and control for height in regression analysis). 
Generally, studies allow for a nonlinear relationship when 
modeling the effects of weight on absenteeism by dividing 
BMI into categories such as under-weight, normal weight, 
overweight, and obese. BMI is most often derived from data 
based on self-reported height and weight. Some studies cor-
rect for potential bias (under- or over- reporting) in data of 
this kind using correlations between self-reported weight and 
height and objectively observed values from NHANES. The 
outcome variables used also vary in definition across stud-
ies. Certain authors, such as Burton et al25 use only longer 
periods of health-related work absence, defined as short-term 
disability, while others use either paid time off for sick leave 
or self-reported absence due to illness.
In order to identify a causal relationship between obesity 
and absenteeism, authors control for a list of observables 
that also affect absenteeism; some authors employ econo-
metric models other than standard ordinary least squares 
(OLS) regressions in order to control for endogeneity of 
weight in determining work absence. Covariates generally 
include demographic variables, years of education, income, 
occupation, smoking or alcohol consumption, and various 
other health risks or conditions. Frone26 runs two sets of 
regressions, the first of which excludes nonweight – related 
physical and mental health conditions, in order to test whether 
the addition of those conditions mediates the effect of obesity 
on absenteeism; he finds that it does.
The result most consistently identified across the studies 
is a positive and statistically significant correlation between 
obesity and measures of absenteeism, even after controlling 
for the covariates discussed above. Because of the differ-
ences in methodologies, the magnitudes of the parameter Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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estimates on obesity are not widely comparable. For example, 
Tsai et al27 find that in the North American division of Shell 
Oil Company, 3.73 additional days of work were lost per 
year for each obese employee relative to their normal-weight 
co-workers, while Serxner et al28 report that employees con-
sidered at risk for obesity were 1.23 times more likely to be 
in the ‘high-absenteeism’ group than those who were not. 
Durden et al29 show that obese workers were 194% more 
likely to use paid time off than their counterparts.
A subset of the authors discussing absenteeism translates 
their results on the correlation between obesity and absentee-
ism into dollar amounts representing the cost of the estimated 
productivity loss. This is usually done by calculating the level 
of compensation for the relevant workers either from survey 
data or BLS averages. Tsai et al27 find that the productivity 
losses to Shell Oil Company alone due to absenteeism effects 
of obesity were worth $11.2 million per year. This amount 
includes only the direct productivity costs of absenteeism 
(that the employee is paid while not at work); it does not 
account for any secondary effects on training, morale, or other 
network effects. Trogdon et al30 provide a range of estimates 
for nationwide annual productivity losses due to obesity-
related absenteeism of between $3.38 billion ($79 per obese 
individual) and $6.38 billion ($132 per obese individual).
Presenteeism
Obesity could also contribute to productivity loss if obese 
individuals are less productive while present at the workplace. 
This may occur as a result of physical and mental health 
conditions that are more common among obese workers and 
negatively affect productive ability. Alternatively, a common 
outside factor may make individuals more likely to both be 
obese and relatively less productive. The studies reviewed 
here focus primarily on the magnitude of the presenteeism 
effect, rather than the mechanism of action.
Studies by Ricci and Chee31 and Pronk et al15 both include 
measures of presenteeism in addition to absenteeism. Ricci 
and Chee use the Caremark American Productivity Audit, a 
phone interview that included several questions regarding 
health-related reduced work performance. Respondents 
were asked to estimate the average amount of time elapsed 
between arriving and starting work on days when they were 
not feeling well, as well as total hours of lost concentration, 
repeating a job, or feeling fatigued. The authors then look at 
total lost productive time (LPT) (the sum of absenteeism and 
presenteeism), and measure the effects of obesity controlling 
for a list of covariates. In a second stage, the authors add a 
variable for the number of co-occurring health conditions to 
test whether the effects of obesity are mediated by overall 
health status. Finally, they convert LPT into dollars using 
workers’ self-reported wages.
Ricci and Chee find that obese workers are more likely 
to have positive LPT than their counterparts, and on average 
have more of it. As also found by Frone,26 this effect appears 
to be largely driven by the higher propensity of obese   workers 
to have co-occurring conditions. The monetary value of the 
cost of excess LPT among obese workers is estimated at 
$11.7 billion per year. Of the total cost of LPT, two-thirds 
is attributable to presenteeism and one-third to absenteeism. 
This finding suggests that while more studies have focused on 
the costs of absenteeism, presenteeism may present a larger 
problem in terms of dollars lost. Additional work is needed 
to clarify the relative magnitudes of these costs.
Pronk et al15 include outcome variables that   measure 
  quality of work performed as well as workplace   inter-personal 
relationships. The only statistically significant   presenteeism 
relationship found with obesity was on inter-personal 
  relationships. However, the study includes physical   activity 
and cardiorespiratory fitness measures as explanatory 
  variables, which are likely to mediate effects of obesity, as 
shown in other studies.
Disability
In addition to absenteeism and presenteeism, obesity may 
lead to an increase in disability payments and disability 
insurance premiums. Such an increase could reflect a loss in 
productivity beyond what is captured in absenteeism data if 
recipients are unable to hold a job altogether. Additionally, an 
increase in the disability rolls represents higher fiscal costs 
to the federal government.
Burkhauser and Cawley32 study the effects of obesity 
both on self-reported work impairment and Social Security 
Disability Insurance. The authors do parallel analyses in 
two datasets: the Panel Survey of Income Dynamics and 
the NLSY. Several econometric specifications are used: 
two OLS models, one linear and one nonlinear, and an 
IV model using a sibling’s or biological child’s weight as an 
  instrument for respondent weight. Potential bias introduced 
by self-reporting of weight is corrected for. Control variables 
include   education, marital status, race, gender, and children 
in a household. Results are robust to specification changes 
for receipt of disability income. For men in the NLSY, being 
obese raises the probability of receiving disability income 
by 6.92 percentage points, which is equivalent to losing 
15.9 years of education. For women, the increased probability 
of receiving disability is 5.64 percentage points, which is Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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the equivalent of losing 16.7 years of education. Thus, even 
after controlling for a list of covariates and endogeneity 
of weight, the authors find a significant and large effect of 
obesity on receipt of disability insurance. More research is 
needed to determine the productivity loss associated with this 
correlation: to what extent does being on disability decrease 
employment among recipients?
Premature mortality
Another form of productivity loss associated with obesity is 
premature mortality or reduction in QALYs. Several studies 
have found a connection between obesity and   mortality.30 
A recent study by Fontaine et al33 measures years of life lost 
due to obesity, controlling for demographic and other factors 
affecting morbidity. The authors determine the   distribution of 
individuals across BMI categories, as well as life   expectancy 
at each age between 18 and 85 years in each BMI category, 
and calculate years of life lost (YLL) in each category relative 
to a reference BMI of 24 (the high end of the   normal-weight 
range). In general, YLLs follows a J- or U- shaped   distribution 
across BMI categories. The largest effect of obesity on 
morbidity was for white men: a white male aged 20 years 
with a BMI over 45 could be expected to have 13 YLLs, the 
equivalent of a 22% reduction in remaining life years. Effects 
for black men and women were much smaller.
Groessel et al34 consider the effects of BMI on quality of 
life in a longitudinal cohort study of older   individuals (mean 
age 72 years). The authors measure QALYs with a   quality of 
  well-being (QWB) scale that rates symptoms and   functionality. 
After controlling for age, sex, smoking and exercise, they com-
pare statistical differences in mean QWB scores between obese 
and nonobese BMI groups. Obese individuals were found to 
have 0.046 lower QWB scores on average, which translates 
into 2.93 million QALYs lost at the national level in the US. 
This result is equivalent to one QALY lost for every 20 people 
who live one year with obesity. Both premature mortality and 
lost QALYs represent important economic impacts of obesity. 
Further research would be needed to monetize this impact for 
comparison with other costs.
Health insurance
Though few studies have considered it, another potential 
  economic cost of obesity is a health insurance market external-
ity. Several studies have estimated the portion of health care 
expenditure on obesity that is paid for by public insurance.35 
However, in addition to the extra medical costs, Bhattacharya 
and Sood35 argue that pooled insurance may actually cause 
a moral hazard that incentivizes overweight and obesity by 
transferring the economic costs away from the obese to the 
larger insurance pool. Such a problem could induce additional 
costs of obesity via welfare loss. The authors note that even 
if an individual does not consciously choose to consume 
more calories or exercise less, pooled insurance reduces the 
price of obesity, and obesity has been shown to be somewhat 
responsive to price signals (eg, food prices).
In order to determine whether there is a welfare loss caused 
by this externality, the authors consider two models of health 
insurance: one in which there is complete, employer-provided, 
pooled insurance, and another in which premiums are risk 
adjusted. The difference in utility under the optimal solution 
in each model is then measured to find welfare loss. After 
calibrating the model using data from the MEPS, the authors 
find that there is in fact a welfare loss under pooled insurance. 
The loss is proportional to the product of the difference in 
medical expenditures between the obese and nonobese, and the 
elasticity of body weight to the insurance subsidy provided by 
pooled insurance. The size of the welfare loss due to the obesity 
externality in the US is estimated at $150 per capita.
Total indirect costs
Several papers have estimated the total economic cost of 
obesity, differentiating only between direct and indirect costs. 
Direct costs include those discussed in the first section of this 
paper, while indirect costs focus on premature   mortality, higher 
disability insurance premiums, and labor market   productivity. 
Notably, the papers reviewed here provide a   reasonably wide 
range of estimates for the total indirect costs of obesity. How-
ever, direct comparison of results across   studies is difficult due 
to such factors as the date of measurement, representativeness 
of the sample, and scope of measurement. Differences in 
findings may be due to a confluence of factors in the design 
of the studies, rather than simply differences in econometric 
specifications or data sources.
For example, Thompson et al36 look at the total cost of 
obesity to US businesses, differentiating between health 
insurance expenditures and paid sick leave, life insurance, 
and disability insurance. The study is based on data from the 
National Health Interview Survey, and BLS and other data 
representing expenditures of all private-sector US firms. 
Using age- and sex-specific obesity-attributable   expenditures, 
the authors estimate that total nonmedical costs of obesity 
among US businesses were $5 billion in 1994. Of that, 
$2.4 billion was spent on paid sick leave, $1.8 billion on 
life insurance, and $0.8 billion on disability insurance. The 
health insurance-related costs of obesity were estimated to 
be $7.7 billion.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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On the other hand, a study by Lightwood et al22 looks 
at current and future costs of adolescent overweight. In this 
case, the indirect costs include work loss due to sick and dis-
ability leave, as well as long-term disability, early retirement, 
and premature mortality. Using employee compensation data, 
along with information on clinical events related to obesity, 
diabetes, and CHD, the authors estimate indirect costs due 
to work absence or reduced work. They project cumulative 
costs from 2020 to 2050 by making assumptions about pro-
ductivity growth and trends in obesity. Likewise, the cost 
of premature mortality is measured using the probability of 
employment for a given age and gender, varying by BMI, 
and is projected forward from 2020 to 2050. The cumulative, 
discounted costs of obesity (including costs due to diabetes 
and CHD) over that period are estimated at $254 billion, 
$208 billion of which is due to indirect costs.
These examples illustrate the substantial differences 
found across studies that provide disaggregated estimates for 
direct and indirect costs of obesity, as well as   absenteeism 
and other sub-categories of indirect costs. The relative 
  significance of indirect to direct costs varies between 65% 
and 88% in these two examples, and in the studies discussed 
above, absenteeism is reported to range from as low as 20% 
of total indirect costs to as high as 50%. Future research 
could effectively parse the source of the differences across 
studies, making results more comparable in order to get a 
better sense of the total and relative magnitudes of obesity’s 
likely economic impacts.
Transportation costs
In addition to its impact on medical spending and produc-
tivity, obesity may affect transportation costs. Increases 
in body weight among Americans mean that more fuel 
and, potentially, larger vehicles are needed to transport the 
same number of commuters and travelers each year. This 
produces a direct cost (in the form of greater spending on 
fuel), as well as potential indirect costs in the form of greater 
greenhouse gas emissions. A number of recent papers assess 
these impacts.
Dannenberg et al37 provide a direct estimate of the 
one-year fuel costs for the passenger airline sector that are 
  associated with increased levels of obesity in US adults from 
1990 to 2000. Using US Dept of Transportation figures for the 
fuel needed to transport a given weight of cargo by air, and 
data on the number of passenger-miles flown, they calculate 
that weight gain during the 1990s required   approximately 
350 million extra gal of jet fuel in the year 2000. At a 
  prevailing price of $0.79/gal, they calculate the extra 
  airline fuel cost due to higher obesity to be   approximately 
$275 million in the year 2000 alone.
Jacobson and King38 use a mathematical model to estimate 
the additional annual fuel consumption by noncommercial 
passenger highway travel in the US that is associated with 
overweight and obesity to be approximately one billion gal. 
At current US prevailing prices,39 this represents a cost of 
$2.7 billion a year. Jacobson and McLay40 provide a similar 
annual estimate of the fuel-use impact of obesity in the US. 
They also estimate that approximately 39 million additional 
gal of fuel (worth $105 million at current prices) are needed 
annually in this sector for each 1 lb of additional average 
passenger weight. Li et al41 also find evidence that a decrease 
in average miles per gal (MPG) in the US passenger vehicle 
fleet may be associated with increased obesity. Although 
cautious in drawing definitive conclusions, they use sales 
data from 1999–2005 to estimate that a 10 percentage point 
increase in overweight/obesity rates reduces average MPG 
of new vehicles sold by approximately 2.5%.
Michaelowa and Dransfield42 conduct an Organization 
for Economic Co-operation and Development (OECD)-wide 
study of the impact of obesity on greenhouse gas emissions 
through three channels: higher fuel consumption needed to 
transport heavier people, greater food production needed 
to feed a population with higher caloric intake, and higher 
  methane emissions resulting from the greater organic waste 
generated by a heavier population. They estimate that reduc-
tion of average weight by 5 kg across the OECD could reduce 
CO2 emissions from the transportation sector by approximately 
10 million T annually. Reduced consumption of energy-rich 
foods to 1990s levels is estimated to lead to savings of approxi-
mately 102 million T. No economic cost estimate is assigned 
to greenhouse gas emissions due to obesity.
Human capital accumulation
Effects of obesity and overweight on educational attainment – 
both quantity and quality of schooling – also represent a 
potential economic impact, one that may become increasingly 
significant as rates of childhood and adolescent obesity climb. 
We review four studies in this section that consider the rela-
tionship between obesity and human capital accumulation.
Gortmaker et al43 include a broad set of outcome variables, 
following a cohort from the NLSY (16 to 24   year-olds) for 
seven years to determine whether membership in a   high-BMI 
category leads to lower income or educational attainment, 
more health conditions, or lower self-esteem. Baseline 
  characteristics were measured in 1979, with obesity defined as 
a BMI over the 95th percentile of the distribution in NHANES, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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given an individual’s age and sex. Self-esteem and   intelligence 
were also measured at baseline. Overall correlations between 
obesity and the outcome variables were statistically significant 
and in the expected directions. Once controls were added for 
baseline characteristics and demographic variables, only select 
correlations remained significant. Women who had been obese 
in the baseline survey had significantly fewer years of school 
completed (0.3 year on average). Likewise, they were less 
likely to be married, had lower household incomes, and higher 
rates of poverty. For men, the only statistically significant 
correlation was for marital status.
Instead of measuring cross-sectional differences in 
  educational attainment as done by Gortmaker et al43 
Kaestner et al44 look at an NLSY cohort to study the effects 
of   obesity on grade progression and drop-out rates. To do 
this, the authors measure the change in the highest grade 
completed by an individual between ages t-1 and t. The study 
includes respondents aged 14 to 17, and models the effects 
of   obesity on grade progression separately for each age, 
using three different models. The first model measures the 
overall   correlation, the second controls for a list of   covariates 
  including family structure and educational attainment, 
respondent health, smoking status, alcohol consumption, 
and region, and the third model instruments weight at age t-1 
with weight in the previous year.
The results are mostly not statistically significant, though 
when they are, the effects are quite large.   Fifteen-year-old 
males in the 90th percentile or above for BMI are 
3.3   percentage points more likely to drop out in the follow-
ing year than their counterparts in the second and third BMI 
quartiles; 16-year old females in the 90th percentile or above 
are 12 percentage points less likely to complete a higher grade 
in the IV model. It is possible that the samples used in this 
study were simply too small to allow for enough statistical 
power to pick up any smaller effects of obesity.
In addition to educational attainment and grade progres-
sion, obesity has also been shown to correlate with school 
attendance. The impact of school attendance on human capital 
and productivity is likely to operate through its effect on edu-
cational attainment; attendance could also affect productivity 
via associated parental work absenteeism. Geier et al45 study 
the effects of overweight and obesity on school attendance, 
and find that days missed from school are significantly higher 
for obese children than their normal-weight counterparts. The 
authors sample just over 1,000 students in nine inner-city Phil-
adelphia schools; they measure their weight and height during 
a school year, and record their absences. Demographic data on 
age, race, and sex are included, in addition to the   fraction of a 
school body on free or reduced school lunch. Controlling for 
covariates, the authors find that while normal-weight children 
missed between 10.1 and 10.5 days of school over the year on 
average, obese children missed between 11.7 and 12.2; the 
difference in means is statistically significant.
Finally, measures of academic performance can provide an 
estimate of the relationship between obesity and the quality of 
education, potentially affecting human capital accumulation 
independently of educational attainment. Sabia46 measures the 
effect of adolescent obesity on grade point average (GPA). The 
author uses data from the NLSY and includes   respondents aged 
14 to 17 who were not pregnant at the time of the survey. GPA 
is measured by combining self-reported grades received in 
English/language arts and Math. Obesity is defined using BMI, 
weight controlling for height, and self-reported perception of 
obesity. Control variables included level of exercise, region, 
intelligence scores, parental   involvement (eg,   Parent-Teacher 
Association participation), family   background, religion, sexual 
behavior, alcohol consumption, and age. The econometric 
specifications include one linear model, another with dummy 
variables for obesity, a third that uses a parent’s self-reported 
weight as an instrument for the child’s, and a fixed effects 
model. However, alternative specifications do not have large 
effects on the major results.
There is a consistent negative relationship between weight 
and GPA among females, though the magnitude is not very 
large. The point estimate for white females from the OLS 
regressions suggests that a 50% increase in BMI would lead 
to a 6.6% decline in GPA, and a 50 lb weight gain would lead 
to a 0.17 point decline in GPA. Obese white females had a 
0.182 point lower GPA on average relative to their nonobese 
counterparts. Sabia notes that while the size of the weight 
gains discussed is large, even a 0.2 point drop in GPA trans-
lates to a drop of eight percentiles. The results for nonwhite 
females are roughly similar in size and significance, with an 
even lower relative mean GPA among the obese group. Among 
males, the only significant correlation is for nonwhites: the 
individuals in the obese group had a 0.18 point lower mean 
GPA than those in the nonobese group.
The studies reviewed here provide statistical evidence of a 
potential link between obesity and the educational experience 
of students. Further research is needed in this area to clarify this 
relationship and identify potential mechanisms of action.
Discussion
The research on the economic impact of obesity reviewed 
above covers a broad range of potential costs. Table 1 
  summarizes some of the key costs identified. Substantial Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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differences in methodology, scope, and data sources often 
make comparison between the studies reviewed difficult, 
and the depth of research varies widely across the four 
impact areas. In addition, this literature does not directly 
address policy choices for reducing obesity nor the likely 
aggregate economic impact associated with such changes.a 
  Nevertheless, several broad conclusions emerge from our 
review.
First, the direct medical costs associated with obesity are 
substantial. The literature reviewed in this paper gives a wide 
range of estimates for these costs, reflecting   differences in 
methodology, definitions of weight categories, age groups 
studied, and data sources. However, all the studies reviewed 
find significant costs. Relative medical spending for the 
obese may be as much as 100% higher than for healthy 
weight adults, and nationwide “excess” medical spending 
may amount to as much as $147 billion annually for adults 
and $14.3 billion annually for children. The estimates of 
direct costs reviewed here may generally be conservative – 
they often rely on self-reported data (which tend to show 
a downward bias in BMI), and focus on a set of obesity-
related diseases more narrow than the full set identified in 
the medical literature. Medical costs appear to have increased 
dramatically over the last decade16 and may continue to grow 
with future increases in rates of overweight and obesity in 
US adults and children, perhaps substantially.47
Second, significant productivity costs are linked with 
  obesity. Productivity effects may fall into at least four   different 
categories (absenteeism, presenteeism, disability, and prema-
ture mortality). Several of the studies reviewed focus on only 
a subset of these effects, and there is extensive variation in 
cost estimates. These factors make comparisons between the 
studies, as well as between medical and productivity costs, dif-
ficult. However, total productivity costs are likely   substantial, 
perhaps as high as $66 billion annually for the US.
Third, important additional economic impacts of obesity 
can be found in the form of transportation costs and human 
capital accumulation costs. The studies reviewed in the final 
two sections of our paper suggest that these effects may be 
significant, but further work is needed to explore their full 
extent and assign consistent economic cost to them.
The overall economic impact of obesity in the US appears 
to be substantial. Although a comprehensive aggregation 
across the different categories of literature is an important 
goal for future research, simple addition of key effects iden-
tified in this review would suggest total annual economic 
costs associated with obesity in excess of $215 billion. The 
magnitude of this impact, and the potential for high future 
impact identified by several studies,16,21,47 underscore the 
importance of the obesity epidemic as a focus for policy and 
a topic for future research.
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